These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 10560747)
1. Structure-activity relationship of short-chain sphingoid bases as inhibitors of sphingosine kinase. De Jonghe S; Van Overmeire I; Poulton S; Hendrix C; Busson R; Van Calenbergh S; De Keukeleire D; Spiegel S; Herdewijn P Bioorg Med Chem Lett; 1999 Nov; 9(21):3175-80. PubMed ID: 10560747 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of sphingoid analogs as inhibitors of sphingosine kinases. Kim JW; Kim YW; Inagaki Y; Hwang YA; Mitsutake S; Ryu YW; Lee WK; Ha HJ; Park CS; Igarashi Y Bioorg Med Chem; 2005 May; 13(10):3475-85. PubMed ID: 15848761 [TBL] [Abstract][Full Text] [Related]
3. Fluorinated triazole-containing sphingosine analogues. Syntheses and in vitro evaluation as SPHK inhibitors. Escudero-Casao M; Cardona A; Beltrán-Debón R; Díaz Y; Matheu MI; Castillón S Org Biomol Chem; 2018 Oct; 16(39):7230-7235. PubMed ID: 30255187 [TBL] [Abstract][Full Text] [Related]
4. Discovery of novel sphingosine kinase 1 inhibitors. Xiang Y; Asmussen G; Booker M; Hirth B; Kane JL; Liao J; Noson KD; Yee C Bioorg Med Chem Lett; 2009 Nov; 19(21):6119-21. PubMed ID: 19800228 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of carbocyclic analogues of pachastrissamine. Kwon Y; Song J; Bae H; Kim WJ; Lee JY; Han GH; Lee SK; Kim S Mar Drugs; 2015 Feb; 13(2):824-37. PubMed ID: 25654428 [TBL] [Abstract][Full Text] [Related]
6. 1-O-Hexadecyl-2-desoxy-2-amino-sn-glycerol, a substrate for human sphingosine kinase. Gijsbers S; Asselberghs S; Herdewijn P; Van Veldhoven PP Biochim Biophys Acta; 2002 Jan; 1580(1):1-8. PubMed ID: 11923095 [TBL] [Abstract][Full Text] [Related]
7. Importance of sphingosine kinase (SphK) as a target in developing cancer therapeutics and recent developments in the synthesis of novel SphK inhibitors. Plano D; Amin S; Sharma AK J Med Chem; 2014 Jul; 57(13):5509-24. PubMed ID: 24471412 [TBL] [Abstract][Full Text] [Related]
8. Polarized membrane traffic and cell polarity development is dependent on dihydroceramide synthase-regulated sphinganine turnover. Van IJzendoorn SC; Van Der Wouden JM; Liebisch G; Schmitz G; Hoekstra D Mol Biol Cell; 2004 Sep; 15(9):4115-24. PubMed ID: 15229289 [TBL] [Abstract][Full Text] [Related]
9. Discovery, biological evaluation, and structure-activity relationship of amidine based sphingosine kinase inhibitors. Mathews TP; Kennedy AJ; Kharel Y; Kennedy PC; Nicoara O; Sunkara M; Morris AJ; Wamhoff BR; Lynch KR; Macdonald TL J Med Chem; 2010 Apr; 53(7):2766-78. PubMed ID: 20205392 [TBL] [Abstract][Full Text] [Related]
10. Type C Niemann-Pick disease: a murine model of the lysosomal cholesterol lipidosis accumulates sphingosine and sphinganine in liver. Goldin E; Roff CF; Miller SP; Rodriguez-Lafrasse C; Vanier MT; Brady RO; Pentchev PG Biochim Biophys Acta; 1992 Aug; 1127(3):303-11. PubMed ID: 1324734 [TBL] [Abstract][Full Text] [Related]
11. 1Alpha,25-dihydroxyvitamin D3 inhibits programmed cell death in HL-60 cells by activation of sphingosine kinase. Kleuser B; Cuvillier O; Spiegel S Cancer Res; 1998 May; 58(9):1817-24. PubMed ID: 9581819 [TBL] [Abstract][Full Text] [Related]
16. N,N-Dimethylsphingosine is a potent competitive inhibitor of sphingosine kinase but not of protein kinase C: modulation of cellular levels of sphingosine 1-phosphate and ceramide. Edsall LC; Van Brocklyn JR; Cuvillier O; Kleuser B; Spiegel S Biochemistry; 1998 Sep; 37(37):12892-8. PubMed ID: 9737868 [TBL] [Abstract][Full Text] [Related]
17. Sphingosine kinase-mediated Ca2+ signalling by G-protein-coupled receptors. Meyer zu Heringdorf D; Lass H; Alemany R; Laser KT; Neumann E; Zhang C; Schmidt M; Rauen U; Jakobs KH; van Koppen CJ EMBO J; 1998 May; 17(10):2830-7. PubMed ID: 9582276 [TBL] [Abstract][Full Text] [Related]